TrialBMC pharmacology & toxicology2022

Granisetron-mediated augmentation of sertraline therapeutic effect in obsessive-compulsive disorder: a double-blind placebo-controlled, randomized clinical trial.

Ala Ghobadian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.